Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study

Simple item page
dc.contributor.authorKoollawat Chupradit
dc.contributor.authorWannisa Khamaikawin
dc.contributor.authorSupachai Sakkhachornphop
dc.contributor.authorChaniporn Puaninta
dc.contributor.authorBruce E. Torbett
dc.contributor.authorSuparerk Borwornpinyo
dc.contributor.authorSuradej Hongeng
dc.contributor.authorMethichit Wattanapanitch
dc.contributor.authorChatchai Tayapiwatana
dc.date.accessioned2026-05-08T19:19:53Z
dc.date.issued2022-2-19
dc.description.abstractHSPC-based gene therapy for AIDS patients.
dc.identifier.doi10.3390/ijms23042331
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/17249
dc.publisherInternational Journal of Molecular Sciences
dc.subjectHIV Research and Treatment
dc.subjectRNA Interference and Gene Delivery
dc.subjectVirus-based gene therapy research
dc.titleEngineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study
dc.typeArticle

Files

Collections

All